Folic acid-conjugated cationic Ag2S quantum dots for optical imaging and selective doxorubicin delivery to HeLa cells

Aim: We aim to develop folic acid (FA)-conjugated cationic Ag2S near-infrared quantum dots (NIRQDs) for the delivery of doxorubicin (DOX) selectively to folate receptor (FR)-positive cancer cells to achieve enhanced drug efficacy and optical tracking in the NIR region. Materials & methods: Catio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nanomedicine (London, England) England), 2017-10, Vol.12 (19), p.2319-2333
Hauptverfasser: Fatma Demir Duman, Erkisa, Merve, Khodadust, Rouhullah, Ferda Ari, Ulukaya, Engin, Havva Yagci Acar
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2333
container_issue 19
container_start_page 2319
container_title Nanomedicine (London, England)
container_volume 12
creator Fatma Demir Duman
Erkisa, Merve
Khodadust, Rouhullah
Ferda Ari
Ulukaya, Engin
Havva Yagci Acar
description Aim: We aim to develop folic acid (FA)-conjugated cationic Ag2S near-infrared quantum dots (NIRQDs) for the delivery of doxorubicin (DOX) selectively to folate receptor (FR)-positive cancer cells to achieve enhanced drug efficacy and optical tracking in the NIR region. Materials & methods: Cationic Ag2S NIRQDs were decorated with FA using a PEG bridge and loaded with DOX. In vitro studies were performed on FR-positive human cervical carcinoma cells and FR-negative A549 cells. Results: Significantly higher uptake of DOX by human cervical carcinoma cells cells and a greater therapeutic effect along with a strong intracellular optical signal were obtained with DOX-loaded FA-conjugated Ag2S NIRQDs. Conclusion: These Ag2S NIRQDs are promising theranostic nanoparticles for receptor-mediated delivery of DOX with enhanced drug efficacy combined with optical imaging.
doi_str_mv 10.2217/nnm-2017-0180
format Article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_miscellaneous_1936265533</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1936265533</sourcerecordid><originalsourceid>FETCH-LOGICAL-p216t-830c30cb050564f79e3c139ea11518856fc1aa99c54e0b96187a0670e38ddc913</originalsourceid><addsrcrecordid>eNpdjk1LAzEQhoMoWKtH7wEvXqKZpMkmx1KsFQoe1HNJs9klZZu0m0T03xs_TsLAO8w8vDwIXQO9Ywya-xD2hFFoCAVFT9AEmpkiUkt--rNzIpTS5-gipR2lQjGgE1SWcfAWG-tbYmPYld5k12Jrso-hPuY9e8HHYkIue9zGnHAXRxwP2VszYL83vQ89NqHFyQ3OZv_uKvYRx7L11gfcuqGexk-cI165tcHWDUO6RGedGZK7-sspels-vC5WZP38-LSYr8mBgcxEcWrrbKmgQs66RjtugWtnAAQoJWRnwRitrZg5utUSVGOobKjjqm2tBj5Ft7-9hzEei0t5s_fp28AEF0vagOaSSSE4r-jNP3QXyxiq3YbxagPAKvcF2hZrhQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2321611255</pqid></control><display><type>article</type><title>Folic acid-conjugated cationic Ag2S quantum dots for optical imaging and selective doxorubicin delivery to HeLa cells</title><source>PubMed Central</source><creator>Fatma Demir Duman ; Erkisa, Merve ; Khodadust, Rouhullah ; Ferda Ari ; Ulukaya, Engin ; Havva Yagci Acar</creator><creatorcontrib>Fatma Demir Duman ; Erkisa, Merve ; Khodadust, Rouhullah ; Ferda Ari ; Ulukaya, Engin ; Havva Yagci Acar</creatorcontrib><description>Aim: We aim to develop folic acid (FA)-conjugated cationic Ag2S near-infrared quantum dots (NIRQDs) for the delivery of doxorubicin (DOX) selectively to folate receptor (FR)-positive cancer cells to achieve enhanced drug efficacy and optical tracking in the NIR region. Materials &amp; methods: Cationic Ag2S NIRQDs were decorated with FA using a PEG bridge and loaded with DOX. In vitro studies were performed on FR-positive human cervical carcinoma cells and FR-negative A549 cells. Results: Significantly higher uptake of DOX by human cervical carcinoma cells cells and a greater therapeutic effect along with a strong intracellular optical signal were obtained with DOX-loaded FA-conjugated Ag2S NIRQDs. Conclusion: These Ag2S NIRQDs are promising theranostic nanoparticles for receptor-mediated delivery of DOX with enhanced drug efficacy combined with optical imaging.</description><identifier>ISSN: 1743-5889</identifier><identifier>EISSN: 1748-6963</identifier><identifier>DOI: 10.2217/nnm-2017-0180</identifier><language>eng</language><publisher>London: Future Medicine Ltd</publisher><subject>Acids ; Apoptosis ; Cancer therapies ; Cervical cancer ; Chemotherapy ; Cytotoxicity ; Drug delivery systems ; Drug efficacy ; Drugs ; Nanoparticles ; Polyethylene glycol ; Quantum dots ; Vitamin B</subject><ispartof>Nanomedicine (London, England), 2017-10, Vol.12 (19), p.2319-2333</ispartof><rights>Copyright Future Medicine Ltd Oct 2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids></links><search><creatorcontrib>Fatma Demir Duman</creatorcontrib><creatorcontrib>Erkisa, Merve</creatorcontrib><creatorcontrib>Khodadust, Rouhullah</creatorcontrib><creatorcontrib>Ferda Ari</creatorcontrib><creatorcontrib>Ulukaya, Engin</creatorcontrib><creatorcontrib>Havva Yagci Acar</creatorcontrib><title>Folic acid-conjugated cationic Ag2S quantum dots for optical imaging and selective doxorubicin delivery to HeLa cells</title><title>Nanomedicine (London, England)</title><description>Aim: We aim to develop folic acid (FA)-conjugated cationic Ag2S near-infrared quantum dots (NIRQDs) for the delivery of doxorubicin (DOX) selectively to folate receptor (FR)-positive cancer cells to achieve enhanced drug efficacy and optical tracking in the NIR region. Materials &amp; methods: Cationic Ag2S NIRQDs were decorated with FA using a PEG bridge and loaded with DOX. In vitro studies were performed on FR-positive human cervical carcinoma cells and FR-negative A549 cells. Results: Significantly higher uptake of DOX by human cervical carcinoma cells cells and a greater therapeutic effect along with a strong intracellular optical signal were obtained with DOX-loaded FA-conjugated Ag2S NIRQDs. Conclusion: These Ag2S NIRQDs are promising theranostic nanoparticles for receptor-mediated delivery of DOX with enhanced drug efficacy combined with optical imaging.</description><subject>Acids</subject><subject>Apoptosis</subject><subject>Cancer therapies</subject><subject>Cervical cancer</subject><subject>Chemotherapy</subject><subject>Cytotoxicity</subject><subject>Drug delivery systems</subject><subject>Drug efficacy</subject><subject>Drugs</subject><subject>Nanoparticles</subject><subject>Polyethylene glycol</subject><subject>Quantum dots</subject><subject>Vitamin B</subject><issn>1743-5889</issn><issn>1748-6963</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpdjk1LAzEQhoMoWKtH7wEvXqKZpMkmx1KsFQoe1HNJs9klZZu0m0T03xs_TsLAO8w8vDwIXQO9Ywya-xD2hFFoCAVFT9AEmpkiUkt--rNzIpTS5-gipR2lQjGgE1SWcfAWG-tbYmPYld5k12Jrso-hPuY9e8HHYkIue9zGnHAXRxwP2VszYL83vQ89NqHFyQ3OZv_uKvYRx7L11gfcuqGexk-cI165tcHWDUO6RGedGZK7-sspels-vC5WZP38-LSYr8mBgcxEcWrrbKmgQs66RjtugWtnAAQoJWRnwRitrZg5utUSVGOobKjjqm2tBj5Ft7-9hzEei0t5s_fp28AEF0vagOaSSSE4r-jNP3QXyxiq3YbxagPAKvcF2hZrhQ</recordid><startdate>20171001</startdate><enddate>20171001</enddate><creator>Fatma Demir Duman</creator><creator>Erkisa, Merve</creator><creator>Khodadust, Rouhullah</creator><creator>Ferda Ari</creator><creator>Ulukaya, Engin</creator><creator>Havva Yagci Acar</creator><general>Future Medicine Ltd</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>EHMNL</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20171001</creationdate><title>Folic acid-conjugated cationic Ag2S quantum dots for optical imaging and selective doxorubicin delivery to HeLa cells</title><author>Fatma Demir Duman ; Erkisa, Merve ; Khodadust, Rouhullah ; Ferda Ari ; Ulukaya, Engin ; Havva Yagci Acar</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p216t-830c30cb050564f79e3c139ea11518856fc1aa99c54e0b96187a0670e38ddc913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Acids</topic><topic>Apoptosis</topic><topic>Cancer therapies</topic><topic>Cervical cancer</topic><topic>Chemotherapy</topic><topic>Cytotoxicity</topic><topic>Drug delivery systems</topic><topic>Drug efficacy</topic><topic>Drugs</topic><topic>Nanoparticles</topic><topic>Polyethylene glycol</topic><topic>Quantum dots</topic><topic>Vitamin B</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fatma Demir Duman</creatorcontrib><creatorcontrib>Erkisa, Merve</creatorcontrib><creatorcontrib>Khodadust, Rouhullah</creatorcontrib><creatorcontrib>Ferda Ari</creatorcontrib><creatorcontrib>Ulukaya, Engin</creatorcontrib><creatorcontrib>Havva Yagci Acar</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>UK &amp; Ireland Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Nanomedicine (London, England)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fatma Demir Duman</au><au>Erkisa, Merve</au><au>Khodadust, Rouhullah</au><au>Ferda Ari</au><au>Ulukaya, Engin</au><au>Havva Yagci Acar</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Folic acid-conjugated cationic Ag2S quantum dots for optical imaging and selective doxorubicin delivery to HeLa cells</atitle><jtitle>Nanomedicine (London, England)</jtitle><date>2017-10-01</date><risdate>2017</risdate><volume>12</volume><issue>19</issue><spage>2319</spage><epage>2333</epage><pages>2319-2333</pages><issn>1743-5889</issn><eissn>1748-6963</eissn><abstract>Aim: We aim to develop folic acid (FA)-conjugated cationic Ag2S near-infrared quantum dots (NIRQDs) for the delivery of doxorubicin (DOX) selectively to folate receptor (FR)-positive cancer cells to achieve enhanced drug efficacy and optical tracking in the NIR region. Materials &amp; methods: Cationic Ag2S NIRQDs were decorated with FA using a PEG bridge and loaded with DOX. In vitro studies were performed on FR-positive human cervical carcinoma cells and FR-negative A549 cells. Results: Significantly higher uptake of DOX by human cervical carcinoma cells cells and a greater therapeutic effect along with a strong intracellular optical signal were obtained with DOX-loaded FA-conjugated Ag2S NIRQDs. Conclusion: These Ag2S NIRQDs are promising theranostic nanoparticles for receptor-mediated delivery of DOX with enhanced drug efficacy combined with optical imaging.</abstract><cop>London</cop><pub>Future Medicine Ltd</pub><doi>10.2217/nnm-2017-0180</doi><tpages>15</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1743-5889
ispartof Nanomedicine (London, England), 2017-10, Vol.12 (19), p.2319-2333
issn 1743-5889
1748-6963
language eng
recordid cdi_proquest_miscellaneous_1936265533
source PubMed Central
subjects Acids
Apoptosis
Cancer therapies
Cervical cancer
Chemotherapy
Cytotoxicity
Drug delivery systems
Drug efficacy
Drugs
Nanoparticles
Polyethylene glycol
Quantum dots
Vitamin B
title Folic acid-conjugated cationic Ag2S quantum dots for optical imaging and selective doxorubicin delivery to HeLa cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T08%3A07%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Folic%20acid-conjugated%20cationic%20Ag2S%20quantum%20dots%20for%20optical%20imaging%20and%20selective%20doxorubicin%20delivery%20to%20HeLa%20cells&rft.jtitle=Nanomedicine%20(London,%20England)&rft.au=Fatma%20Demir%20Duman&rft.date=2017-10-01&rft.volume=12&rft.issue=19&rft.spage=2319&rft.epage=2333&rft.pages=2319-2333&rft.issn=1743-5889&rft.eissn=1748-6963&rft_id=info:doi/10.2217/nnm-2017-0180&rft_dat=%3Cproquest%3E1936265533%3C/proquest%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2321611255&rft_id=info:pmid/&rfr_iscdi=true